Companies / Evaxion A/S

Evaxion A/S

Nasdaq: EVAXCIK 1828253HOERSHOLM

Financials · FY2025

Revenue$7.53M
Net income$-7.71M
Total debt
Cash$23.23M
Diluted EPS$-0.81
Shares outstanding417.0M

Ownership

417.0M shares outstanding
0.36%Institutions
Ownership
Institutions0.36%1,513,896
Public float99.64%415,496,860

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Evaxion A/SOfficer · Director
Holtug LarsDirector
Rono BirgitteChief Scientific Officer
Schmidt Thomas FrederikChief Financial Officer
Tayton-Martin Helen KatrinaCEOChief Executive Officer

Institutional holders 17

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
Merck & Co., Inc.
13F manager
NewADR$3.76M+1.2M
1,214,126
0.29% of shares
low
Q1 2026
as of
Rathbones Group PLC
13F manager
NewADR$170.1K+46K
45,723
0.01% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
NewADR$145.9K+39K
39,225
<0.01% of shares
low
Q1 2026
as of
Royal Bank of Canada
13F manager
ExitADR$-19.0K-4K
-100.00%
0
low
Q1 2026
as of
Rhumbline Advisers
13F manager
AddADR$2.1K+569
+2.70%
21,659
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
EVAXADREquity29970R303BBG00YTSS733